Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcitriol + iron supplements is a combination nutritional/supplementation regimen consisting of calcitriol (the active hormonal form of vitamin D, also known as 1,25-dihydroxyvitamin D3) and iron supplements (specifically iron polysaccharide complex). This combination is being investigated by Guangdong Provincial People's Hospital in a randomized, open-label clinical trial for patients with obsessive-compulsive disorder (OCD). Calcitriol acts as an agonist on the vitamin D receptor (VDR), a nuclear receptor involved in immune modulation, neuroprotection, and neurotransmitter regulation. Iron is an essential mineral and a critical cofactor for enzymes involved in dopamine synthesis and immune-neural homeostasis. The combination is hypothesized to correct vitamin D and iron deficiencies, thereby normalizing glutamatergic metabolism in the anterior cingulate-thalamic circuit and improving inhibitory control deficits associated with OCD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcitriol + iron supplements.